President Trump expected to announce a deal with drugmakers Eli Lilly and Novo Nordisk to lower the price of their weight loss drugs in exchange for limited Medicare coverage, according to people familiar with the plan. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures t ...

Everyone declared victory when Pfizer and the White House reached a deal on drug pricing, but it deserves scrutiny (via @opinion) https://t.co/essgQTlHl0 ...

One of the sort of miracle drugs right now that everyone's talking about are GLP-1s and how they have so many applications. Obviously, they're very expensive. The last administration had talked about opening them up to people.Obviously, it's a big upfront cost, but ultimately because it makes people healthier down the line, it might pay off. What are your thoughts on making GLP1s available for weight loss in Medicare. Can we afford it or can we afford not to do it.>> Uh, it's the only question I'm going to ...

President Trump announcing a drug pricing deal with Fizer, which will voluntarily sell its medications for less, including discounted drug prices for Medicaid. Fizer is up 5% on the news. Angelica Peoples joins us now with more.There was a tease or two that other drug companies would have announcements to come also. That's what the president said. We haven't heard anything yet.I've been checking in. Nothing to announce there. But, you know, this is interesting, right.Of course, we've been hearing from all t ...

Morning, Frank. Well, we haven't heard many companies making concrete promises. Most are telling us that they're in talks with the administration and that they don't have anything to share just yet.Now, we have heard a number of CEOs like Lily's CEO Dave Ricks and Merks Rob Davis say that they agree with President Trump that other countries should pay more for drugs, but we haven't seen many actions to actually raise prices elsewhere. Now, Lily and Bristol are making a few tweaks, but nothing groundbreaking ...

Bristol has broken from some of its peers in embracing the White House's ideas about drug pricing. https://t.co/fGuINgKJBc ...

Company Strategy - Cost Plus Drugs launched in 2022 to increase transparency in drug pricing [1] - The company aims to lower drug costs for the average consumer [1] - The company intends to disrupt the traditional pharmacy industry [1]

FDA offers to trade faster drug reviews for lower US prices https://t.co/NwGHqOHqhE ...